Farms.com Home   Ag Industry News

Global wheat genome project advances breeding

Global wheat genome project advances breeding

The University of Saskatchewan-led project sequenced 15 wheat varieties around the world

 
Staff Writer
Farms.com

Wheat growers on the Prairies could see new varieties faster thanks to a recent global research study.

The University of Saskatchewan (USask)-led international study involved close to 100 scientists from around the world, said Sean Walkowiak. He is the lead author on the study and a research scientist with the Canadian Grain Commission.

“The wheat genomes from the study are an important leap forward because the wheat community can now use these genomes to identify genes and differences in the DNA. This can be used to improve wheat and develop new cultivars with improved genetics,” he told Farms.com.

Scientists sequenced 15 wheat varieties in the study, including two from Canada: CDC Landmark and CDC Stanley.

This work is significant because the wheat genome has historically been challenging, said Walkowiak.

“The wheat genome has largely been a black box until recently. So, now that we have multiple genomes from different growing regions and that carry different traits. We can use the genomes to really get at those traits and make our breeding and crop improvement more efficient,” he said.

Funding for this project on the Canadian side includes involvement from the Canadian Triticum Applied Genomics research project funded by Genome Canada, Genome Prairie, the Western Grains Research Foundation, Government of Saskatchewan, Saskatchewan Wheat Development Commission, Alberta Wheat Commission, Viterra, Manitoba Wheat and Barley Growers Association, and the Canada First Research Excellence Fund through USask’s Plant Phenotyping and Imaging Research Centre initiative, said the USask release.

mareandmare/iStock/Getty Images Plus photo


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.